These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11555135)

  • 1. The importance of the relation between lipoprotein(a) and lipids for development of atherosclerosis and cardiovascular disease.
    Dahlén GH; Ekstedt B
    J Intern Med; 2001 Sep; 250(3):265-7. PubMed ID: 11555135
    [No Abstract]   [Full Text] [Related]  

  • 2. Relation between low-density lipoprotein cholesterol and thoracic aortic atherosclerosis.
    Tribouilloy CM; Peltier M; Iannetta-Peltier MC; Zhu Z; Andréjak M; Lesbre JP
    Am J Cardiol; 1999 Sep; 84(5):603-5, A9. PubMed ID: 10482166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and atherosclerosis. A two-pronged approach to treatment.
    Tzagournis M
    Postgrad Med; 1987 May; 81(6):242-9, 252. PubMed ID: 3575196
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipoprotein(a) as a biochemical marker of coronary atherosclerosis].
    Ezhov MV; Afanas'ev OI; Benevolenskaia GF; Savchenko AP; Liakishev AA; Pokrovskiĭ SN
    Ter Arkh; 1997; 69(9):31-4. PubMed ID: 9411822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of common carotid intima-media thickness and lipoprotein(a) with coronary artery disease.
    Tewari S; Garg N; Kapoor A; Jain A; Singh U; Godbole MM; Sinha N
    Indian Heart J; 2004; 56(6):642-5. PubMed ID: 15751520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis.
    Sentí M; Pedro-Botet J; Pavesi M; Marrugat J; Aubó C; Pena A; Martín S; Rubiés-Prat J
    Clin Chim Acta; 1997 Aug; 264(2):193-205. PubMed ID: 9293377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of coronary heart disease in men with androgenetic alopecia.
    Sasmaz S; Senol M; Ozcan A; Dogan G; Tuncer C; Akyol O; Sener S
    J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):123-5. PubMed ID: 10343940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Homocysteine--CRP--lipoprotein (a). When do you evaluate the "new" risk factors].
    Parhofer KG
    MMW Fortschr Med; 2001 Jan; 143(4):22-4. PubMed ID: 11219276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.
    Yamamoto A; Horibe H; Mabuchi H; Kita T; Matsuzawa Y; Saito Y; Nakaya N; Fujioka T; Tenba H; Kawaguchi A; Nakamura H; Goto Y
    Atherosclerosis; 1999 Mar; 143(1):55-73. PubMed ID: 10208480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [HDL-cholesterol--active or passive participant in the pathogenesis of atherosclerosis? (II)].
    Artenie A; Artenie R; Ungureanu D; Botnariu G; Anisies E; Ionescu SD; Cosovanu A
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(3):503-8. PubMed ID: 15832963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indicators of atherosclerosis risk. Evaluation with coronary angiography in non diabetic men with total cholesterol levels equal to or below 240 mg/dl].
    Arteaga A; Martínez A; Pollak F; Borghesi L; Catalán L; Acosta AM; Leighton F
    Rev Med Chil; 1995 Feb; 123(2):145-57. PubMed ID: 7569454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of plasma high density lipoprotein cholesterol (hdlc).
    Gupta S; Rajagopal G
    Nepal Med Coll J; 2007 Sep; 9(3):212-4. PubMed ID: 18092443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of menopause on high density lipoprotein-cholesterol and lipids.
    Kim CJ; Kim TH; Ryu WS; Ryoo UH
    J Korean Med Sci; 2000 Aug; 15(4):380-6. PubMed ID: 10983684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic cause of unstable atherosclerotic plaques.
    Violi F; Loffredo L
    Lancet; 2000 Apr; 355(9212):1362; author reply 1363-4. PubMed ID: 10776764
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipoprotein(a) and coronary artery disease: ongoing debate.
    Celik T; Yuksel C; Iyisoy A; Isik E
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):e33-4. PubMed ID: 18472410
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipoprotein(a). Clinical approach to a unique atherogenic lipoprotein.
    Rader DJ; Brewer HB
    JAMA; 1992 Feb; 267(8):1109-12. PubMed ID: 1531241
    [No Abstract]   [Full Text] [Related]  

  • 18. [Lipoprotein(a) as a risk factor for arteriosclerosis].
    Steinmetz A; Utermann G
    Internist (Berl); 1992 Jan; 33(1):24-31. PubMed ID: 1532383
    [No Abstract]   [Full Text] [Related]  

  • 19. [Editorial comment: lipoprotein (a) and coronary artery disease].
    Soydan I
    Anadolu Kardiyol Derg; 2001 Dec; 1(4):264-5. PubMed ID: 12803215
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum Lp(a) lipoprotein levels in patients with atherosclerotic occlusive disease of the lower extremities.
    Dionyssiou-Asteriou A; Papastamatiou M; Vatalas I; Bastounis E
    Eur J Vasc Endovasc Surg; 2000 Jul; 20(1):57-60. PubMed ID: 10906299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.